Global Artificial Insemination Market Research Report—Forecast till 2027

Table of Contents

TABLE OF CONTENT 1 EXECUTIVE SUMMARY 2 MARKET INTRODUCTION 2.1 SCOPE OF THE STUDY 14 2.2 RESEARCH OBJECTIVE 14 2.3 MARKET STRUCTURE 14 2.4 ASSUMPTIONS & LIMITATIONS 15 3 RESEARCH METHODOLOGY 3.1 DATA MINING 16 3.2 SECONDARY RESEARCH 17 3.3 PRIMARY RESEARCH 18 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 19 3.5 FORECASTING TECHNIQUES 19 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 20 3.6.1 BOTTOM-UP APPROACH 21 3.6.2 TOP-DOWN APPROACH 21 3.7 DATA TRIANGULATION 22 3.8 VALIDATION 22 4 MARKET DYNAMICS 4.1 OVERVIEW 23 4.2 DRIVERS 24 4.2.1 GROWING RATE OF INFERTILITY IN THE WORLD 24 4.2.2 CHANGING LIFESTYLE AMONG POPULATION 24 4.2.3 RISE IN NHS FUNDED IN FERTILITY MARKET 24 4.3 RESTRAINTS 25 4.3.1 HIGH RISK OF CONCEIVING TWINS OR TRIPLETS AND OTHER COMPLICATIONS SUCH AS PREMATURE BIRTH OR MISCARRIAGE 25 4.4 OPPORTUNITIES 26 4.4.1 MEDICAL INSURANCE FOR THE COUPLES OF SAME SEXES 26 5 MARKET FACTOR ANALYSIS 5.1 VALUE CHAIN ANALYSIS 27 5.1.1 CONSULTING DOCTOR FOR EVALUATION 27 5.1.2 FERTILITY TESTING OF MALE & FEMALE 28 5.1.3 DIAGNOSIS 28 5.1.4 INSEMNINATION OF SPERM 28 5.2 PORTER’S FIVE FORCES MODEL 29 5.2.1 BARGAINING POWER OF SUPPLIERS 29 5.2.2 BARGAINING POWER OF BUYERS 29 5.2.3 THREAT OF NEW ENTRANTS 29 5.2.4 THREAT OF SUBSTITUTES 30 5.2.5 RIVALRY 30 5.3 COVID-19 IMPACT ANALYSIS 30 5.3.1 IMPACT ON GROWTH RATE 30 5.3.2 IMPACT ON MAJOR PLAYERS 30 5.3.3 IMPACT ON MAJOR REGIONS 30 6 GLOBAL ARTIFICIAL INSEMINATION MARKET, BY TYPE 6.1 OVERVIEW 32 6.2 INTRAUTERINE 33 6.3 INTRACERVICAL 33 6.4 INTRATUBAL 34 7 GLOBAL ARTIFICIAL INSEMINATION MARKET, BY END USER 7.1 OVERVIEW 35 7.2 HOSPITALS & CLINICS 36 7.3 FERTILITY CENTRE 36 7.4 HOME-BASED 37 8 GLOBAL ARTIFICIAL INSEMINATION MARKET, BY REGION 8.1 OVERVIEW 38 8.2 AMERICAS 39 8.2.1 NORTH AMERICA 40 8.2.1.1 US 41 8.2.1.2 CANADA 42 8.2.2 LATIN AMERICA 43 8.3 EUROPE 44 8.3.1 WESTERN EUROPE 45 8.3.1.1 GERMANY 47 8.3.1.2 FRANCE 47 8.3.1.3 UK 48 8.3.1.4 ITALY 49 8.3.1.5 SPAIN 49 8.3.1.6 BELGIUM 50 8.3.1.7 SWEDEN 51 8.3.1.8 DENMARK 51 8.3.1.9 FINLAND 52 8.3.1.10 NORWAY 53 8.3.1.11 REST OF WESTERN EUROPE 53 8.3.2 EASTERN EUROPE 54 8.4 ASIA-PACIFIC 55 8.4.1 JAPAN 56 8.4.2 CHINA 57 8.4.3 INDIA 58 8.4.4 AUSTRALIA 58 8.4.5 SOUTH KOREA 59 8.4.6 REST OF ASIA-PACIFIC 60 8.5 MIDDLE EAST & AFRICA 61 8.5.1 MIDDLE EAST 62 8.5.2 AFRICA 63 9 COMPETITIVE LANDSCAPE 9.1 OVERVIEW 64 9.2 COMPETITIVE BENCHMARKING 65 9.3 COMPETITOR DASHBOARD 66 9.4 MAJOR GROWTH STRATEGY IN THE GLOBAL ARTIFICIAL INSEMINATION MARKET 67 9.5 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL ARTIFICIAL INSEMINATION MARKET 67 9.6 KEY DEVELOPMENT ANALYSIS 68 9.7 KEY DEVELOPMENTS & GROWTH STRATEGIES 68 9.7.1 PARTNERSHIPS/COLLABORATIONS/AGREEMENTS 68 9.7.2 EXPANSIONS 68 10 COMPANY PROFILES 10.1 VITROLIFE AB 69 10.1.1 COMPANY OVERVIEW 69 10.1.2 FINANCIAL OVERVIEW 70 10.1.3 PRODUCTS/SERVICES OFFERED 71 10.1.4 KEY DEVELOPMENTS 71 10.1.5 SWOT ANALYSIS 72 10.1.6 KEY STRATEGIES 72 10.2 GENEA LIMITED 73 10.2.1 COMPANY OVERVIEW 73 10.2.2 FINANCIAL OVERVIEW 73 10.2.3 PRODUCTS/SERVICES OFFERED 73 10.2.4 KEY DEVELOPMENTS 73 10.2.5 SWOT ANALYSIS 74 10.2.6 KEY STRATEGIES 74 10.3 RINOVUM WOMEN’S HEALTH, LLC 75 10.3.1 COMPANY OVERVIEW 75 10.3.2 FINANCIAL OVERVIEW 75 10.3.3 PRODUCTS/SERVICES OFFERED 75 10.3.4 KEY DEVELOPMENTS 75 10.3.5 SWOT ANALYSIS 76 10.3.6 KEY STRATEGIES 76 10.4 PRIDE ANGEL 77 10.4.1 COMPANY OVERVIEW 77 10.4.2 FINANCIAL OVERVIEW 77 10.4.3 PRODUCTS/SERVICES OFFERED 77 10.4.4 KEY DEVELOPMENTS 77 10.4.5 SWOT ANALYSIS 78 10.4.6 KEY STRATEGIES 78 10.5 HI-TECH SOLUTIONS 79 10.5.1 COMPANY OVERVIEW 79 10.5.2 FINANCIAL OVERVIEW 79 10.5.3 PRODUCTS/SERVICES OFFERED 79 10.5.4 KEY DEVELOPMENTS 79 10.5.5 SWOT ANALYSIS 80 10.5.6 KEY STRATEGIES 80 10.6 KITAZATO CORPORATION 81 10.6.1 COMPANY OVERVIEW 81 10.6.2 FINANCIAL OVERVIEW 81 10.6.3 PRODUCTS/SERVICES OFFERED 81 10.6.4 KEY DEVELOPMENTS 82 10.6.5 SWOT ANALYSIS 82 10.6.6 KEY STRATEGIES 82 10.7 FUJIFILM IRVINE SCIENTIFIC, INC. 83 10.7.1 COMPANY OVERVIEW 83 10.7.2 FINANCIAL OVERVIEW 83 10.7.3 PRODUCTS/SERVICES OFFERED 84 10.7.4 KEY DEVELOPMENTS 84 10.7.5 SWOT ANALYSIS 84 10.7.6 KEY STRATEGIES 85 10.8 ROCKET MEDICAL 86 10.8.1 COMPANY OVERVIEW 86 10.8.2 FINANCIAL OVERVIEW 86 10.8.3 PRODUCTS/SERVICES OFFERED 87 10.8.4 KEY DEVELOPMENTS 87 10.8.5 SWOT ANALYSIS 87 10.8.6 KEY STRATEGIES 87 11 APPENDIX 11.1 REFERENCES 88 11.2 RELATED REPORTS 89